Developing improved therapies for cytomegalovirus infections by overcoming viral strain diversity. [ 1/1/2021 - 12/31/2024 ]

Research Grant

Brief description Cytomegalovirus infection is the most common cause of infection-related disease in newborns and is one of the most common complications in transplant patients. Current treatments are not always successful and are associated with significant side-effects. We have therefore developed world first systems that can be used to develop safer, more effective treatments for this life-threatening infection. Our findings are likely to be applicable to other difficult to manage viral infections.

Funding Amount $1,126,820

Funding Scheme Ideas Grants

Chief Investigator Prof Mariapia Degli-Esposti

Notes Ideas Grants